(Q37880625)

24 August 2017

1 reference

title

Mesenchymal stromal cell 'licensing': a multistep process (English)

1 reference

24 August 2017

M Krampera

1

1 reference

24 August 2017

27 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

25

1 reference

24 August 2017

1408-1414

1 reference

24 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2011.108

24 August 2017

0 references

cites work

Mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cells: the fibroblasts' new clothes?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Marrow stromal cells as stem cells for nonhematopoietic tissues

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Regenerative and immunomodulatory potential of mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Comparison of multi-lineage cells from human adipose tissue and bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human mesenchymal stem cells modulate B-cell functions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Immune Regulation by Mesenchymal Stem Cells Derived from Adult Spleen and Thymus

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Interferon-gamma and NF-kappaB mediate nitric oxide production by mesenchymal stromal cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

The role of mesenchymal stem cells in haemopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human mesenchymal stem cells promote survival of T cells in a quiescent state.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Comparative studies of different stromal cell microenvironments in support of human B-cell development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

IFNgamma and B7-H1 in the immunology of mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Toll-like receptors and their ligands control mesenchymal stem cell functions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Toll-Like Receptors 3 and 4 Are Expressed by Human Bone Marrow-Derived Mesenchymal Stem Cells and Can Inhibit Their T-Cell Modulatory Activity by Impairing Notch Signaling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Macrophage polarization comes of age.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Coevolution of cancer and stromal cellular responses

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.108

7 January 2021

Identifiers

DOI

10.1038/LEU.2011.108

1 reference

PubMed ID

21617697

Dimensions Publication ID

24 August 2017

0 references

1 reference

PubMed ID

21617697